hemotune Analysis: $26M Raised
What is hemotune?
hemotune specializes in a magnetic nanoparticle platform that enables targeted blood purification by removing harmful agents directly from the bloodstream. Their technology is applicable in various medical therapies and biomanufacturing processes, aiming to enhance treatment efficacy and safety. The company collaborates with industry leaders to address complex separation challenges.
Location
Wagistrasse 27, Schlieren, Zurich 8952, Switzerland
Employees
11-50
Founded
2017
Funding Status
Series B
Product Features & Capabilities
- HemoBeads for multi-target precision
- HemoSystem for life-saving therapies
Use Cases
Deplete antibodies for safer gene therapy; Purify blood to restore immune balance in sepsis; Solve bioseparation challenges in industrial applications
Other Considerations
Supported by VentureKick; Collaborates with EIT Health; Recognized by Wyss Zurich; Engaged with Eurostars program
See something that needs updating? Suggest edits to this profile.